FAABORG PHARMA A/S: Financial statements 2021
CVR: 26190770
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
FAABORG PHARMA A/S (CVR 26190770) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 6,979,843 and a net result of DKK 31,438 compared with DKK 3,991,734 the year before. That is a decrease of 38.2% compared with the year before. Equity in the 2021 report amounted to DKK 4,824,351. The solvency ratio was 32.9%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 6,979,843
- Profit/Loss
- DKK 31,438
- Equity
- DKK 4,824,351
- Total Assets
- DKK 14,651,722
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 7 mio. | 31 t. | 4.8 mio. | 15 |
| 2020 | - | 11.3 mio. | 4 mio. | 4.8 mio. | 11 |
| 2019 | - | 6.5 mio. | 713 t. | 801 t. | 11 |
| 2018 | - | 6.8 mio. | 2.1 mio. | 88 t. | 9 |
| 2017 | - | 4.6 mio. | 510 t. | -2 mio. | 8 |
Official annual report
Find more companies like FAABORG PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
FAABORG PHARMA A/S has published its annual report for 2020. Gross profit came to DKK 11,292,076, and the net result was DKK 3,991,734.
About FAABORG PHARMA A/S
FAABORG PHARMA A/S is a Danish company of the type Aktieselskab based in Faaborg, founded in 2001. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named FAABORG PHARMA ApS and FAABORG LØVE PRODUKTER ApS. The management consists of Frank Hauken Vibæk. The board consists of Claus Wædeled (chair), Birk Simon Maldonado Andersen and Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 13,336,305 and a net result of DKK 747,032 compared with DKK 1,762,826 the year before. Equity in the 2025 report amounted to DKK 10,503,744.